Hunterdon Pharmaceuticals Inc form joint venture Chesapeake Biological Laboratories> E.B. Michaels Research Associates> develop C31G substance useful treatment prevention plaque. The substance test pre-clinical trial University Pennsylvania us anti-fungal anti-bacterial agent company said. It Chesapeake Biological private company own 55 pct venture E.B. Michaels 10 pct hold remain patent C31G. Reuter 